Search

UCLA scientists receive $6.9M in CIRM grants to develop novel stem-cell based therapies

Researchers received more than $6.9 million in grants from the California Institute for Regenerative Medicine.

UCLA researchers identify possible approach to prevent cancer from evolving to resist treatment

Commonly used antiretroviral drugs used to treat HIV and hepatitis B reduce immune cells’ energy production

Commonly used antiretroviral drugs used to treat HIV and hepatitis B reduce immune cells’ energy production

Mental health healer, heal thyself

Commonly used antiretroviral drugs used to treat HIV and hepatitis B reduce immune cells’ energy production

For patients with localized prostate cancer, MRI-guided radiotherapy promotes better quality of life

Classification System for Reporting on Skin Biopsies of Melanocytic Lesions

International group updates a classification system that makes skin biopsy pathology reports easier for patients and medical teams to understand

MRI-guided radiotherapy produces fewer side effects and better quality of life for patients with localized prostate cancer

For men who undergo radiotherapy for localized prostate cancer, the precise targeting capabilities of MRI guidance resulted in fewer toxicities and be...

Tiny implantable device designed by UCLA scientists helps kill cancer

A therapeutic sponge the size of a pencil eraser boosted the body’s tumor-fighting response in mice and kept the cancer from returning.

UCLA AIDS researchers receive $3 million in grants toward ending HIV in vulnerable populations

The UCLA Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) and the UCLA-Charles R....